The Journal of Urology
Volume 182, Issue 2 , Pages 425-426, August 2009

Prognostic Implications of Polymorphisms and Interleukin-2 Therapy for Renal Cell Carcinoma

  • Thomas A. Gardner

      Affiliations

    • Department of Urology, Indiana University Simon Cancer Center and Walther Oncology Center, Indianapolis, Indiana
    • ,
  • Theodore Logan

      Affiliations

    • Division of Hematology and Oncology, Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana

published online 15 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0022-5347(09)01260-9

doi:10.1016/j.juro.2009.05.073

The Journal of Urology
Volume 182, Issue 2 , Pages 425-426, August 2009

Article Tools